Jaineya, Myra .

HRN: 13-33-05  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/11/2022
09/18/2022
IV
1.2g
Q6hours
Sepsis Sec To AGE With Severe Dehydration
Waiting Final Action 

Indication:  Empiric    Type of Infection:  BloodstreamIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: